Biologically defined neuronal synuclein disease as a tool to advance drug development. - Pagano G; Dam T; Kerchner GA; Galpern WR; Biagioni M; Karan R; Jennings D; Peterschmitt MJ; Nikolcheva T; Brundin P (NPJ Parkinson's disease, 2024)